Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAM | P19021 | 2/20 | 1.00 |
| ▸ | DGKA | P23743 | 1/20 | 0.67 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.58 |
| ▸ | PPARG | P37231 | 7/20 | 0.58 |
| ▸ | PPARD | Q03181 | 7/20 | 0.58 |
| ▸ | PPARA | Q07869 | 7/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.58 |
| ▸ | TSHR | P16473 | 5/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TLR2 | O60603 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | FABP4 | P15090 | 2/20 | 0.58 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.58 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | PDE4A | P27815 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11345548 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL27957389 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL7773521 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL7775439 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL11354026 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL2116872 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL11047565 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL10555970 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL8671140 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD | |
| SCHEMBL9602505 | 1.00 | PAM (1.00) | PAMDGKAGPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0003794-B1 | TESTOSTERONE ESTERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1981-01-28 | — | — | EP | claimed |
| CN-119296764-A | Marker for detecting sensitivity of tumor radiotherapy and screening method and application thereof | 福建医科大学附属协和医院 | 2025-01-10 | — | — | CN | disclosed |
| CN-119165078-A | Combined marker for detecting tumor radiotherapy sensitivity and application thereof | 福建医科大学附属协和医院 | 2024-12-20 | — | — | CN | disclosed |
| US-20230304002-A1 | TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES | BANK OF AMERICA, N.A. | 2023-09-28 | — | — | US | disclosed |
| US-20230272382-A1 | COMPLEMENT COMPONENT C3 iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING COMPLEMENT COMPONENT C3-ASSOCIATED DISEASES | BANK OF AMERICA, N.A. | 2023-08-31 | — | — | US | disclosed |
| CN-112390576-A | Potassium titanate whisker modified high-strength high-hydrophobicity porous geopolymer thermal insulation material and preparation method and application thereof | 武汉工程大学 | 2021-02-23 | — | — | CN | disclosed |
| WO-2008019070-A2 | PHARMACEUTICAL COMPOSITIONS OF TROSPIUM FOR TREATING SMOOTH MUSCLE HYPERACTIVITY DISORDERS | VERSI EBRAHIM (US) | 2008-02-14 | — | — | WO | disclosed |
| US-4337311-A | 15 Hydroxylation of 1α,2α-methylene steroids | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-06-29 | — | — | US | disclosed |
| US-4277468-A | CONTRACEPTIVES, PROGESTATIONAL ACTIVITY | SCHERING AKTIENGESELLSCHAFT (DE) | 1981-07-07 | — | — | US | disclosed |
| US-4196204-A | ANTIANDROGENS, ACNE, SEBORRHEA | SCHERING AKTIENGESELLSCHAFT (DE) | 1980-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230304002-A1 | TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES | TTR, MTPN, CRYAA | PAM 4870/4885DGKA 3847/4885GPR84 3736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.